Regenxbio vs Travere Therapeutics
Regenxbio vs Travere Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Regenxbio is on 55/100 and Travere Therapeutics on 51/100.
Where each one leads
Regenxbio
- our overall score: 55/100 against 51/100
- headcount: 396 against 125
- funding raised: $180M against $63.0M
Travere Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Regenxbio | Travere Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2008 | 2015 |
| Headquarters | Rockville, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Regenxbio | Travere Therapeutics |
|---|---|---|
| Employees | 396 | 125 |
| Total funding | $180M | $63.0M |
| Latest round | Funding Round | Convertible Note |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 49,536 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Regenxbio | Travere Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 51/100 |
| Traction | 60/100 | 59/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 24/100 | 5/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Regenxbio | Travere Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery, Tailwind CSS |
| Analytics | Google Tag Manager | Google Tag Manager, Linkedin Insight |
Regenxbio vs Travere Therapeutics: common questions
Which is better, Regenxbio or Travere Therapeutics?
On our 0-100 score Regenxbio rates higher (55/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Regenxbio and Travere Therapeutics compare on the numbers?
Regenxbio leads on our overall score (55/100 against 51/100), headcount (396 against 125), funding raised ($180M against $63.0M).
Read the full Regenxbio review and pricing or the Travere Therapeutics review and pricing. You can also browse other Regenxbio alternatives we track.